Churchill Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
RJA
RJFSA
Churchill Management's FBT Position: Q4 2018 in Review
Churchill Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 2,180,380 shares — an estimated $346M sold.
Churchill Management first reported a position in FBT in Q2 2013 and held it in 15 quarters. The position peaked at $346M in Q3 2018. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.
- Churchill Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
- Churchill Management sold 2,180,380 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $346M.
- Churchill Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 15 quarters.
- Churchill Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $346M in Q3 2018.
- 194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.
Based on Churchill Management's 13F filing for Q4 2018, filed 15 Jan 2019.